Glutamine-blocking drug slows tumor growth and strengthens anti-tumor response

(Johns Hopkins Medicine) A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.